Presentation is loading. Please wait.

Presentation is loading. Please wait.

Enhanced DNA damage in IDH1 mutant glioma cells.

Published byΕυάγγελος Αλιβιζάτος Modified over 6 years ago

Similar presentations

Presentation on theme: "Enhanced DNA damage in IDH1 mutant glioma cells."— Presentation transcript:

1 Enhanced DNA damage in IDH1 mutant glioma cells.
Enhanced DNA damage in IDH1 mutant glioma cells. A, Western blotting for γH2A.X expression in IDH1 mutant cells. Protein expression level was determined by densitometry analysis. B, Immunostaining for γH2A.X puncta in IDH1 mutant cells. C, Comet assay demonstrates DNA fragmentation in IDH1 mutant cells. D, Quantitative analysis showed enhancement in DNA fragmentation in IDH1-mutated cells. Yanxin Lu et al. Cancer Res 2017;77: ©2017 by American Association for Cancer Research

Download ppt "Enhanced DNA damage in IDH1 mutant glioma cells."

Similar presentations

Metabolic reprogramming results in chemosensitivity in IDH1 mutant cells. Metabolic reprogramming results in chemosensitivity in IDH1 mutant cells. A,

Metabolic reprogramming results in chemosensitivity in IDH1 mutant cells. Metabolic reprogramming results in chemosensitivity in IDH1 mutant cells. A,
Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.

Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.
IDH1 mutant glioma cells are sensitive to TMZ

IDH1 mutant glioma cells are sensitive to TMZ
Pirh2 promotes p73 ubiquitination in vivo.

Pirh2 promotes p73 ubiquitination in vivo.
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.

25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
β-ARs signal cooperatively with mutant EGFR and inactivate LKB1

β-ARs signal cooperatively with mutant EGFR and inactivate LKB1
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.

Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
Dihydromyricetin decreases the sphere formation through downregulation of Sox2 in human osteosarcoma. Dihydromyricetin decreases the sphere formation through.

Dihydromyricetin decreases the sphere formation through downregulation of Sox2 in human osteosarcoma. Dihydromyricetin decreases the sphere formation through.
Bringing IDH into the Fold

Bringing IDH into the Fold
Fig. 2. BET inhibition enhances PARPi-induced DNA damage.

Fig. 2. BET inhibition enhances PARPi-induced DNA damage.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.

JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.

Time-dependent effects of IL-6 on tyrosine phosphorylation of IRS-1.
IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.

IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.
DNA damage foci accumulate at a subset of telomeres in cells expressing a mutant-template telomerase RNA. Immunostaining was done for telomere-protective.

DNA damage foci accumulate at a subset of telomeres in cells expressing a mutant-template telomerase RNA. Immunostaining was done for telomere-protective.
Cell viability assay and expression of COX protein.

Cell viability assay and expression of COX protein.
A, scheme of the APC cDNA and the mutant APC cDNAs which were used for reporter gene assays. A, scheme of the APC cDNA and the mutant APC cDNAs which were.

A, scheme of the APC cDNA and the mutant APC cDNAs which were used for reporter gene assays. A, scheme of the APC cDNA and the mutant APC cDNAs which were.
Variation in dUTPase expression in cell lines.

Variation in dUTPase expression in cell lines.
Mapping the Pirh2 and p73 interaction sites.

Mapping the Pirh2 and p73 interaction sites.
BME treatment increases granzyme B expression in NK 3.3 cells.

BME treatment increases granzyme B expression in NK 3.3 cells.
DNA damage signaling regulates mutant p53 ubiquitination.

DNA damage signaling regulates mutant p53 ubiquitination.

Similar presentations

Ads by Google